| ELEDON PHARMACEUT.DL-,001 |
| USA |
| Gesundheit |
| US28617K1016 / A2QL00 |
| 2TK (Frankfurt) / ELDN (NASDAQ) |
| FRA:2TK, ETR:2TK, 2TK:GR, NASDAQ:ELDN |
| - |
| https://eledon.com/ |
|
Eledon Pharmaceuticals Inc. is a clinical-stage bi..
>Volltext.. |
| 179.21 Mio. EUR |
| 135.9 Mio. EUR |
| - |
| -75.45 Mio. EUR |
| -6.79 Mio. EUR |
| 0.06 EUR |
| 0.69 Mio. EUR |
| 4.94 Mio. EUR |
| -55.49 Mio. EUR |
| 7.84 |
| - |
| 95.64% |
| - |
| - |
| - |
| - |
| ELEDON |
| 28.10.25 |
|
||||
|
||||
|
||||
|
||||
|